{"schema_version":"secwatch.filing_event.v1","accession":"0001553350-22-000181","form_type":"8-K","ticker":"ASPU","cik":"0001487198","company_name":"ASPEN GROUP, INC.","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.683178+00:00","generated_at":"2026-06-27T04:44:55.097425+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aspen Group cuts revenue growth forecast to 9% after suspending Phoenix BSN pre-licensure cohorts","bullets":["Net loss of $3.7M for first six months of FY2022 vs 17% loss margin in prior-year period.","Corporate expenses approximately $20M per annum; forecasts net loss for FY2023 then breakeven.","Revenue growth plan cut from 17% ($13M) to 9% ($7M) due to voluntary suspension of new Phoenix cohorts.","Suspension follows guidance from Arizona State Board of Nursing on January 28, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001553350-22-000181","json":"https://secwatch.observer/filing/0001553350-22-000181.json","markdown":"https://secwatch.observer/filing/0001553350-22-000181.md","text":"https://secwatch.observer/filing/0001553350-22-000181.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1487198/000155335022000181/0001553350-22-000181-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1487198/000155335022000181/aspu_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:44:55.097425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}